172 related articles for article (PubMed ID: 10769704)
1. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Fukushima T; Yamamoto M; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 1998; 18(5D):3965-70. PubMed ID: 9854511
[TBL] [Abstract][Full Text] [Related]
3. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.
Yamada Y; Webber EM; Kirillova I; Peschon JJ; Fausto N
Hepatology; 1998 Oct; 28(4):959-70. PubMed ID: 9755232
[TBL] [Abstract][Full Text] [Related]
4. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
Börset M; Medvedev AE; Sundan A; Espevik T
Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
[TBL] [Abstract][Full Text] [Related]
5. Sequence, genomic organization, and chromosome localization of the mouse TRADD gene.
Pan MG; Xiong J; Copeland NG; Gilbert DJ; Jenkins NA; Goeddel DV
J Inflamm; 1995-1996; 46(3):168-75. PubMed ID: 8844497
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of the nuclear factor-kappa B by TNF muteins specific for the p60 and p80 TNF receptors.
Chainy GB; Singh S; Raju U; Aggarwal BB
J Immunol; 1996 Sep; 157(6):2410-7. PubMed ID: 8805640
[TBL] [Abstract][Full Text] [Related]
7. One and two-level regulation patterns affecting NF-kappa B mRNA and nuclear NF-kappa B activity after treatment with TNF-alpha, IFN-gamma and IL-4.
Vassiliadis S; Stravopodis D; Kyrpides N; Grigoriou M; Papamatheakis J
Eur Cytokine Netw; 1993; 4(1):25-30. PubMed ID: 8490102
[TBL] [Abstract][Full Text] [Related]
8. Mutations which abolish phosphorylation of the TRAF-binding domain of TNF receptor 2 enhance receptor-mediated NF-kappa B activation.
Ng PW; Jänicke RU; Porter AG
Biochem Biophys Res Commun; 1998 Mar; 244(3):756-62. PubMed ID: 9535738
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor necrosis factor-alpha and its receptors type I and type II in human oocytes.
Naz RK; Zhu X; Menge AC
Mol Reprod Dev; 1997 Jun; 47(2):127-33. PubMed ID: 9136112
[TBL] [Abstract][Full Text] [Related]
10. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
Yamada SM; Bruner JM; Berger MS; Morrison RS
No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
Yamamoto M; Ikeda K; Ohshima K; Tsugu H; Kimura H; Tomonaga M
Cancer Res; 1997 Jul; 57(13):2799-805. PubMed ID: 9205092
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Varakis I
Anticancer Res; 1997; 17(4A):2677-82. PubMed ID: 9252700
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of serial MRI and histological findings following intra-tumor local chemotherapy for malignant brain tumor].
Shimura T; Nakazawa S; Takahashi H; Node Y; Tamai J; Kumazaki T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):209-18. PubMed ID: 8311491
[TBL] [Abstract][Full Text] [Related]
14. Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasms.
Braczkowski R; Zubelewicz B; Romanowski W; Lissoni P; Brivio F
J Exp Clin Cancer Res; 1998 Sep; 17(3):349-54. PubMed ID: 9894774
[TBL] [Abstract][Full Text] [Related]
15. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.
Aderka D; Sorkine P; Abu-Abid S; Lev D; Setton A; Cope AP; Wallach D; Klausner J
J Clin Invest; 1998 Feb; 101(3):650-9. PubMed ID: 9449699
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans.
DeLa Cadena RA; Majluf-Cruz A; Stadnicki A; Tropea M; Reda D; Agosti JM; Colman RW; Suffredini AF
Thromb Haemost; 1998 Jul; 80(1):114-8. PubMed ID: 9684796
[TBL] [Abstract][Full Text] [Related]
17. Endogenous TNF induction therapy using rTNF-SAM2 in patients with pulmonary metastases from colorectal cancer.
Yamasaki K; Hasegawa S; Futami K; Arima S
Anticancer Res; 1998; 18(5D):3931-6. PubMed ID: 9854506
[TBL] [Abstract][Full Text] [Related]
18. Release of tumor necrosis factor alpha and its soluble receptor p55 in clinical septic syndrome.
Modzelewski B
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):213-9. PubMed ID: 9597089
[TBL] [Abstract][Full Text] [Related]
19. Formulation and antitumor efficacy of liposomal-caprylated-TNF-SAM2.
Akimaru K; Auzenne E; Akimaru Y; Leroux ME; Hayman AC; Utsumi T; Soma G; Klostergaard J
Cytokines Mol Ther; 1995 Sep; 1(3):197-210. PubMed ID: 9384676
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
Korshunov AG; Sycheva RV
Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
